BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28508357)

  • 1. Biofluid Proteomics and Biomarkers in Traumatic Brain Injury.
    Azar S; Hasan A; Younes R; Najdi F; Baki L; Ghazale H; Kobeissy FH; Zibara K; Mondello S
    Methods Mol Biol; 2017; 1598():45-63. PubMed ID: 28508357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid proteomics in multiple sclerosis.
    Kroksveen AC; Opsahl JA; Guldbrandsen A; Myhr KM; Oveland E; Torkildsen Ø; Berven FS
    Biochim Biophys Acta; 2015 Jul; 1854(7):746-56. PubMed ID: 25526888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application.
    Jaber Z; Aouad P; Al Medawar M; Bahmad H; Abou-Abbass H; Ghandour H; Mondello S; Kobeissy F
    Methods Mol Biol; 2016; 1462():157-74. PubMed ID: 27604718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics: in pursuit of effective traumatic brain injury therapeutics.
    Lizhnyak PN; Ottens AK
    Expert Rev Proteomics; 2015 Feb; 12(1):75-82. PubMed ID: 25603864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biomarkers and MEG-based imaging markers in the diagnosis of post-traumatic stress disorder and blast-induced mild traumatic brain injury.
    Huang M; Risling M; Baker DG
    Psychoneuroendocrinology; 2016 Jan; 63():398-409. PubMed ID: 25769625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers.
    Mondello S; Hayes RL
    Handb Clin Neurol; 2015; 127():245-65. PubMed ID: 25702221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury.
    Manek R; Moghieb A; Yang Z; Kumar D; Kobessiy F; Sarkis GA; Raghavan V; Wang KKW
    Mol Neurobiol; 2018 Jul; 55(7):6112-6128. PubMed ID: 29188495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain injury and proteomics/peptidomics: is it relevant? an overview.
    Schuhmann MU; Heine G; Skardelly M; Jaeger M; Selle H
    Acta Neurochir Suppl; 2005; 95():465-70. PubMed ID: 16463902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of traumatic brain injury: the search for biomarkers.
    Prieto DA; Ye X; Veenstra TD
    Expert Rev Proteomics; 2008 Apr; 5(2):283-91. PubMed ID: 18466057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofluid biomarkers of traumatic brain injury.
    Agoston DV; Shutes-David A; Peskind ER
    Brain Inj; 2017; 31(9):1195-1203. PubMed ID: 28981341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage.
    Mondello S; Schmid K; Berger RP; Kobeissy F; Italiano D; Jeromin A; Hayes RL; Tortella FC; Buki A
    Med Res Rev; 2014 May; 34(3):503-31. PubMed ID: 23813922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries.
    Sarkis GA; Mangaonkar MD; Moghieb A; Lelling B; Guertin M; Yadikar H; Yang Z; Kobeissy F; Wang KK
    Curr Neurol Neurosci Rep; 2017 Mar; 17(3):23. PubMed ID: 28283963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.
    Kobeissy FH; Guingab-Cagmat JD; Razafsha M; O'Steen L; Zhang Z; Hayes RL; Chiu WT; Wang KK
    PM R; 2011 Jun; 3(6 Suppl 1):S139-47. PubMed ID: 21703572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic identification of biomarkers of traumatic brain injury.
    Wang KK; Ottens AK; Liu MC; Lewis SB; Meegan C; Oli MW; Tortella FC; Hayes RL
    Expert Rev Proteomics; 2005 Aug; 2(4):603-14. PubMed ID: 16097892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroproteomics Studies: Challenges and Updates.
    Ramadan N; Ghazale H; El-Sayyad M; El-Haress M; Kobeissy FH
    Methods Mol Biol; 2017; 1598():3-19. PubMed ID: 28508355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model.
    Crawford F; Crynen G; Reed J; Mouzon B; Bishop A; Katz B; Ferguson S; Phillips J; Ganapathi V; Mathura V; Roses A; Mullan M
    J Neurotrauma; 2012 Jan; 29(2):246-60. PubMed ID: 21895520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates.
    Hanrieder J; Wetterhall M; Enblad P; Hillered L; Bergquist J
    J Neurosci Methods; 2009 Mar; 177(2):469-78. PubMed ID: 19263575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.